Expert Consensus on the Management of the multidisciplinary Team of Glioma in China (2nd Edition)

Title: Expert Consensus on the Management of the multidisciplinary Team of Glioma in China (2nd Edition)
Edition: Updated
Classification: Experts consensus
Field: Administration
Countries and regions: China
Guidelines users: National-Region-Local glioma diagnosis and treatment center (team), and all units of the National Glioma MDT Alliance of the National Center for Neurological Diseases.
Evidence classification method: modified Oxford Centre for Evidence-based Medicine (OCEBM)
Development unit: National Center for Neurological Disorders
Registration time: 2022-12-05
Registration number: PREPARE-2022CN795
Purpose of the guideline: Based on the currently available evidence-based evidence, to update the consensus of Chinese experts on the multidisciplinary diagnosis and treatment (MDT) of glioma. Improve the understanding of clinicians on the MDT of glioma, formulate the implementation requirements and standards, and provide reference and guidance for clinicians.